Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
leuprolide (lupron) (1 trial)
alfuzosin (uroxatral) (1 trial)
Erectile Dysfunction (Phase 3)
Lower Urinary Tract Symptoms (Phase 3)
Prostatic Neoplasms (Phase 4)
Trials (2 total)
Trial APIs (2 total)